- Home
- HKPD
as 05-30-2025 4:00pm EST
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
| Founded: | 2016 | Country: | Hong Kong |
| Employees: | N/A | City: | N/A |
| Market Cap: | 11.9M | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 2.9M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.21 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.81 - $3.79 | Next Earning Date: | 01-01-0001 |
| Revenue: | $20,770,344 | Revenue Growth: | 32.91% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares News
HKPD Breaking Stock News: Dive into HKPD Ticker-Specific Updates for Smart Investing
GOBankingRates
7 hours ago
7 Summer Side Hustles That Can Pay $1,000 a Week or More
Yahoo Finance Video
7 hours ago
Will Tesla have to play catch up to Waymo's robotaxis?
Yahoo Finance
7 hours ago
Why Scott Bessent wants to make it easier for banks to own Treasurys
The Guardian
7 hours ago
When are people too old to do their jobs?
GlobeNewswire
7 hours ago
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
GlobeNewswire
7 hours ago
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
PR Newswire
7 hours ago
Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population
CNW Group
7 hours ago
Statement by Minister Guilbeault on Portuguese Heritage Month
Compare HKPD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.